Immediate Impact
9 standout
Citing Papers
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database
2024 Standout
The Immunology of Psoriasis—Current Concepts in Pathogenesis
2024 Standout
Works of L. Renda being referenced
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*
2020
Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L. Renda | 175 | 105 | 33 | 36 | 9 | 198 | |
| M. Viguier | 174 | 139 | 36 | 36 | 12 | 233 | |
| Manan D. Mehta | 201 | 113 | 41 | 44 | 7 | 294 | |
| Christopher S. Carlin | 217 | 138 | 33 | 50 | 8 | 281 | |
| Jackie Lu | 209 | 98 | 24 | 43 | 6 | 281 | |
| L. Manounah | 169 | 139 | 27 | 35 | 9 | 290 | |
| Murali Sundaram | 145 | 81 | 29 | 50 | 6 | 197 | |
| A. Galluccio | 186 | 154 | 29 | 62 | 10 | 262 | |
| Stephanie Mehlis | 241 | 143 | 52 | 46 | 14 | 291 | |
| Federico Pirrò | 145 | 109 | 37 | 42 | 11 | 193 | |
| Amanda Abramson Lloyd | 125 | 123 | 33 | 41 | 8 | 195 |
All Works
Loading papers...